Pharma
EuroAPI Revision and FOCUS-27 Plan: Divestment of Facilities in Brindisi, Italy and Haverhill, UK in 2027
- WACKER & CordenPharma Prepare for Pandemic Readiness on June 1, 2024 Following Successful Expansion and Qualification in Halle, Germany
- Heinlein Plastik-Technik Joins the ALPLA Group
- Merck Invests € 62 Million in New Quality Control Facility in Darmstadt, Germany
- WACKER Opens mRNA Competence Center in Halle an der Saale, Germany
- Asahi Kasei to Acquire Calliditas Therapeutics for SEK 11.8 Billion
Pharma projects
A map of Pharma projects that are planned or currently being executed.
Use chemXplore Analytics to power your research into Pharma.
Scheduled completion
This chart shows how many Pharma projects in the European chemical industry are expected to be completed in the upcoming years.
- Roquette makes strategic move by signing agreement to acquire IFF Pharma Solutions
- Daiichi Sankyo invests approximately one billion euros in expanding its site into an international innovation center in Pfaffenhofen, Bavaria, Germany
- PanTera signs agreement with Bayer for actinium-225 supply from Mol, Belgium location
- Schedule of Global Bioenergies' new biobased isobutene plant for cosmetics in France is specified.
- Agreement to Sell Athlone, Ireland Facility to Novo Nordisk Announced by Alkermes plc
- Expansion of production facilities in Chartres, France receives over 2.1 billion euros investment from Novo Nordisk.
- Novo Nordisk's investment in expansion of manufacturing facilities in Kalundborg, Denmark exceeds 5.6 billion Euro.
- Lonza Stein (CH) Introduces New Filling Line for Commercial Supply of Antibody-Drug Conjugates to Exclusive Customer
- BioNTech Strengthens Pioneering Position in AI-Powered Drug Discovery, Design, and Development with Completion of InstaDeep Acquisition
- Global Bioenergies raises ambitions for increased future isobutene plant sizing in France
- Novo Nordisk to invest €2.1bn in expanding manufacturing facilities in Hillerød, Denmark
- BASF boosts alkoxylates production capacity in Antwerp, Belgium, and Ludwigshafen, Germany
- WACKER strengthens its biotechnology business with the acquisition of ADL Biopharma in Leon, Spain
- Dexcom chooses Athenry Galway, Ireland as its first European manufacturing site.
- Lonza Finishes Manufacturing Line for Clinical and Commercial Drug Products in Visp (CH)
- Sandoz to Construct New Biologics Production Plant in Lendava, Slovenia, to Meet Growing Global Demand for Biosimilar Medicines
- Moderna chooses Harwell science campus in Oxfordshire for the establishment of its innovation and technology center in the UK.
- Getinge, a Swedish manufacturer, to set up UK headquarters in Derby.
- Expansion of Conjugation Facility in Visp, Switzerland Successfully Completed by Lonza
- Merck Enhances Manufacturing Capabilities in Molsheim, France with Over € 130 Million Investment
- MetaboGen and BioGaia inaugurate pilot plant for novel bacterial strains in Eslöv, Sweden
- Novartis plans to create a standalone company by separating Sandoz business through a 100% spin-off.
New construction vs expansion
Owners & Investors
Top 5 companies involved as owner and/or investor in current and planned Pharma projects:
Merck, WACKER, Novo Nordisk, Sandoz, Lonza, Asahi Kasei, Orlen, SEQENS, Global Bioenergies, and Nouryon.
